These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 17660844

  • 21. High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation.
    Baron F, Maris MB, Storer BE, Sandmaier BM, Panse JP, Chauncey TR, Sorror M, Little MT, Maloney DG, Storb R, Heimfeld S.
    Leukemia; 2005 May; 19(5):822-8. PubMed ID: 15772701
    [Abstract] [Full Text] [Related]

  • 22. Non-total body irradiation myeloablative conditioning with intravenous busulfan and cyclophosphamide in hematopoietic stem cell transplantation for malignant infantile osteopetrosis.
    Behfar M, Dehghani SS, Hosseini AS, Jalali A, Hamidieh AA, Ghavamzadeh A.
    Pediatr Transplant; 2015 Jun; 19(4):422-7. PubMed ID: 25879376
    [Abstract] [Full Text] [Related]

  • 23. Which donor should be chosen for hematopoietic stem cell transplantation among unrelated HLA-A, -B, and -DRB1 genomically identical volunteers?
    Ringdén O, Schaffer M, Le Blanc K, Persson U, Hauzenberger D, Abedi MR, Olerup O, Ljungman P, Remberger M.
    Biol Blood Marrow Transplant; 2004 Feb; 10(2):128-34. PubMed ID: 14750078
    [Abstract] [Full Text] [Related]

  • 24. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
    Meisel R, Enczmann J, Balzer S, Bernbeck B, Kramm C, Schönberger S, Sinha K, Tröger A, Wernet P, Göbel U, Laws HJ, Dilloo D.
    Klin Padiatr; 2005 Feb; 217(3):135-41. PubMed ID: 15858704
    [Abstract] [Full Text] [Related]

  • 25. Unrelated cord blood transplant experience by the pediatric blood and marrow transplant consortium.
    Yu LC, Wall DA, Sandler E, Chan KW, Grayson G, Kletzel M.
    Pediatr Hematol Oncol; 2001 Jun; 18(4):235-45. PubMed ID: 11400647
    [Abstract] [Full Text] [Related]

  • 26. Hematopoietic stem cell transplantation for multiply transfused patients with sickle cell disease and thalassemia after low-dose total body irradiation, fludarabine, and rabbit anti-thymocyte globulin.
    Horan JT, Liesveld JL, Fenton P, Blumberg N, Walters MC.
    Bone Marrow Transplant; 2005 Jan; 35(2):171-7. PubMed ID: 15531901
    [Abstract] [Full Text] [Related]

  • 27. Nonmyeloablative stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemia in patients 60 years or older.
    Gupta V, Daly A, Lipton JH, Hasegawa W, Chun K, Kamel-Reid S, Tsang R, Yi QL, Minden M, Messner H, Kiss T.
    Biol Blood Marrow Transplant; 2005 Oct; 11(10):764-72. PubMed ID: 16182177
    [Abstract] [Full Text] [Related]

  • 28. Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia.
    Iannone R, Casella JF, Fuchs EJ, Chen AR, Jones RJ, Woolfrey A, Amylon M, Sullivan KM, Storb RF, Walters MC.
    Biol Blood Marrow Transplant; 2003 Aug; 9(8):519-28. PubMed ID: 12931121
    [Abstract] [Full Text] [Related]

  • 29. Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update.
    Bethge WA, Faul C, Bornhäuser M, Stuhler G, Beelen DW, Lang P, Stelljes M, Vogel W, Hägele M, Handgretinger R, Kanz L.
    Blood Cells Mol Dis; 2008 Aug; 40(1):13-9. PubMed ID: 17869547
    [Abstract] [Full Text] [Related]

  • 30. Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities.
    Sorror ML, Maris MB, Storer B, Sandmaier BM, Diaconescu R, Flowers C, Maloney DG, Storb R.
    Blood; 2004 Aug 15; 104(4):961-8. PubMed ID: 15113759
    [Abstract] [Full Text] [Related]

  • 31. Unrelated umbilical cord blood transplantation in children with immune deficiency: results of a multicenter study.
    Frangoul H, Wang L, Harrell FE, Manes B, Calder C, Domm J.
    Bone Marrow Transplant; 2010 Feb 15; 45(2):283-8. PubMed ID: 19543326
    [Abstract] [Full Text] [Related]

  • 32. Nonmyeloablative stem cell transplantation with CD8-depleted or CD34-selected peripheral blood stem cells.
    Baron F, Baudoux E, Frère P, Tourqui S, Schaaf-Lafontaine N, Greimers R, Herens C, Fillet G, Beguin Y.
    J Hematother Stem Cell Res; 2002 Apr 15; 11(2):301-14. PubMed ID: 11983101
    [Abstract] [Full Text] [Related]

  • 33. Related HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: observations of a single Chinese center.
    Huang X, Liu D.
    Clin Transpl; 2011 Apr 15; ():237-45. PubMed ID: 22755417
    [Abstract] [Full Text] [Related]

  • 34. Successful treatment of stem cell graft failure in pediatric patients using a submyeloablative regimen of campath-1H and fludarabine.
    Ahmed N, Leung KS, Rosenblatt H, Bollard CM, Gottschalk S, Myers GD, Carrum G, Heslop HE, Brenner MK, Krance RA.
    Biol Blood Marrow Transplant; 2008 Nov 15; 14(11):1298-304. PubMed ID: 18940685
    [Abstract] [Full Text] [Related]

  • 35. Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Baron F, Maris MB, Sandmaier BM, Storer BE, Sorror M, Diaconescu R, Woolfrey AE, Chauncey TR, Flowers ME, Mielcarek M, Maloney DG, Storb R.
    J Clin Oncol; 2005 Mar 20; 23(9):1993-2003. PubMed ID: 15774790
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Feasibility of reduced intensity hematopoietic stem cell transplantation from an HLA-matched unrelated donor.
    Kusumi E, Kami M, Yuji K, Hamaki T, Murashige N, Hori A, Kojima R, Kishi Y, Kim SW, Ueyama J, Miyakoshi S, Tanosaki R, Morinaga S, Mori S, Heike Y, Muto Y, Masuo S, Taniguchi S, Takaue Y.
    Bone Marrow Transplant; 2004 Apr 20; 33(7):697-702. PubMed ID: 14755317
    [Abstract] [Full Text] [Related]

  • 38. Unrelated donor hematopoietic stem cell transplantation for patients with hematologic malignancies using a nonmyeloablative conditioning regimen of fludarabine, low-dose total body irradiation, and rabbit antithymocyte globulin.
    Rowley SD, Goldberg SL, Pecora AL, Hsu JS, Brecher BA, Butrin L, Kobbe K, McKiernan P, Preti R.
    Biol Blood Marrow Transplant; 2004 Nov 20; 10(11):784-93. PubMed ID: 15505609
    [Abstract] [Full Text] [Related]

  • 39. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
    Mengarelli A, Iori A, Guglielmi C, Romano A, Cerretti R, Torromeo C, Micozzi A, Fenu S, Laurenti L, Donato V, De Felice L, Arcese W.
    Haematologica; 2002 Jan 20; 87(1):52-8. PubMed ID: 11801465
    [Abstract] [Full Text] [Related]

  • 40. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N, Le Deist F, Cant A, De Graeff-Meeders ER, Fasth A, Morgan G, Vellodi A, Hale G, Bujan W, Thomas C, Cavazzana-Calvo M, Wijdenes J, Fischer A.
    Pediatrics; 1996 Sep 20; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.